98%
921
2 minutes
20
Purpose: Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) rank among the most common sexually transmitted pathogens. Rapid screening and detection of these bacteria are essential to reduce sequelae and prevent transmission. This study evaluated the efficacy of the EasyNAT CT/NG assay, which utilizes cross-priming amplification (CPA) technique for the rapid and simultaneous detection of CT and NG in diverse reproductive tract specimens, achieving diagnosis within 30 min.
Methods: The clinical performance of the EasyNAT CT/NG assay in detecting CT and NG was assessed using 198 clinical samples, with results compared to those of conventional in-house Real-Time PCR to determine concordance. Sensitivity was measured using serial dilutions of quantified plasmids and specificity was evaluated by incorporating DNA from 18 common STI pathogens. The assay's suitability as a point-of-care testing (POCT) tool was evaluated with the criteria outlined in Target Product Profiles (TPPs).
Results: The EasyNAT CT/NG assay demonstrated high concordance with Real-Time PCR, with rates of 98.5% for CT and 99.0% for NG. Concordance in urine samples reached 98.6% for CT and 100% for NG, while cervical swabs showed both 97.7% for CT and NG; vaginal and urethral swabs achieved 100% for both pathogens. Among the 198 samples, one urine specimen tested negative for CT by Real-Time PCR but positive by the EasyNAT CT/NG assay, a positive result confirmed by the Cepheid Xpert CT/NG assay. Two cervical swabs, negative for CT and NG by Real-Time PCR, yielded invalid results with the EasyNAT CT/NG assay but were confirmed negative or CT and NG by the Cepheid Xpert CT/NG assay. The EasyNAT CT/NG assay reliably detected CT and NG in turbid specimens, though it may fail with severely hemolytic samples. Its detection limit was 400 copies/mL, with no cross-reactivity observed across 18 other pathogens.
Conclusion: The EasyNAT CT/NG assay offers rapid, sensitive, and specific detection of CT and NG, proving valuable for infection screening and early diagnosis. It shows promise as a rapid POCT method.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10096-025-05218-1 | DOI Listing |
J Appl Lab Med
September 2025
Infectious Disease Diagnostics Laboratory, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
Background: Testing for sexually transmitted infections (STIs) in preadolescent patients carries significant medical and legal implications. Guidelines from the Centers for Disease Control and Prevention (CDC) support the use of nucleic acid amplification testing (NAAT) for diagnosis of Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) in children. These guidelines also recommend confirmation of positive results by repeat testing of either the original specimen or a separately collected specimen to reduce the risk of false positives.
View Article and Find Full Text PDFRapid point-of-care (POC) diagnostics are essential tools for improving timely treatment and reducing the transmission of sexually transmitted infections (STIs). The STI NG Plus Assay is a rapid multiplex LAMP (loop-mediated isothermal amplification) NAAT (nucleic acid amplification test) capable of simultaneously detecting (CT), (NG), (TV), and fluoroquinolone resistance-associated mutations in NG ( S91F). In this study, we assessed the STI NG Plus assay primer design and analytical sensitivity.
View Article and Find Full Text PDFEnferm Infecc Microbiol Clin (Engl Ed)
August 2025
Department of Microbiology, Hospital Clínic, Barcelona, Spain; ISGlobal, Barcelona, Spain. Electronic address:
Introduction: Detection of Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) is periodically indicated in asymptomatic patients with risky sexual practices. The objective of this study was to assess the efficacy of employing a rapid polymerase chain reaction (PCR) test in a combined pool of three samples from the same patient and compare it with the standard PCR performed in the three different samples separately.
Methods: Samples were collected from asymptomatic patients at risk of sexually transmitted infections (STI).
BMJ Open
August 2025
Department of Medicine, University of Washington, Seattle, Washington, USA.
Objectives: To assess the prevalence, incidence and factors associated with (CT) and (NG) infection among HIV-negative men who have sex with men (MSM) and transgender women (TGW) in Kenya.
Design: Prospective cohort.
Setting: Kisumu, Nairobi and coastal Kenya.
Sensors (Basel)
July 2025
School of Software, Hallym University, Chuncheon-si 24252, Republic of Korea.
The Internet of Medical Things (IoMT) is revolutionizing healthcare by integrating smart diagnostic devices with cloud computing and real-time data analytics. The emergence of infectious diseases, including COVID-19, underscores the need for rapid and decentralized diagnostics to facilitate early intervention. Traditional centralized laboratory testing introduces delays, limiting timely medical responses.
View Article and Find Full Text PDF